Raymond James initiates Milestone Pharmaceuticals stock coverage with Strong Buy

요약

“Raymond James initiated coverage on Milestone Pharmaceuticals with a Strong Buy rating and $6.00 price target”
“The target represents nearly 200% upside from current stock price of $2.02”
“Firm believes Cardamyst has strong commercial potential in treating PSVT”

Profit ▼ Debt high Cash good Valuation neutral Drawdown high Recent recovery

Raymond James, Milestone Pharmaceuticals 주식 커버리지 시작, Strong Buy 등급 부여
Raymond James, Milestone Pharmaceuticals에 Strong Buy 등급과 $6.00 목표주가 부여
현재 주가 $2.02 대비 약 200% 상승 잠재력 반영
Cardamyst가 PSVT 치료에서 강력한 상업적 잠재력 보유한다고 판단

출처: Investing.com
링크: https://www.investing.com/news/analyst-ratings/raymond-james-initiates-milestone-pharmaceuticals-stock-coverage-with-strong-buy-93CH-4606828

소셜 공유 미리보기(OG) 전용 페이지입니다.